PGP and Respiratory insufficiency due to muscle weakness: Administration of the drug to P-gp-deficient mice or co-administration with a P-gp blocker both increase brain levels and trigger central effects typically observed with brain penetrant opioids, such as analgesia [52], [53] or respiratory depression [54].